4DMedical Limited
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function im… Read more
4DMedical Limited (FDMDF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.316x
Based on the latest financial reports, 4DMedical Limited (FDMDF) has a cash flow conversion efficiency ratio of -0.316x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-20.33 Million) by net assets ($64.24 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
4DMedical Limited - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how 4DMedical Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
4DMedical Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 4DMedical Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VEF AB (Publ)
PINK:VEFFF
|
-0.001x |
|
Yatas Yatak ve Yorgan Sanayi Ticaret AS
IS:YATAS
|
0.116x |
|
Lucky Strike Entertainment Corporation
NYSE:LUCK
|
0.074x |
|
Baozun Inc
NASDAQ:BZUN
|
0.000x |
|
Kaveri Seed Company Limited
NSE:KSCL
|
-0.083x |
|
Shanghai Karon Eco-Valve Manufacturing Co. Ltd.
SHE:301151
|
0.168x |
|
Modiv Inc
NYSE:MDV
|
0.020x |
|
Kelly Partners Group Holdings Limited
OTCQX:KPGHF
|
0.052x |
Annual Cash Flow Conversion Efficiency for 4DMedical Limited (2015–2025)
The table below shows the annual cash flow conversion efficiency of 4DMedical Limited from 2015 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $64.24 Million | $-34.48 Million | -0.537x | -23.33% |
| 2024-06-30 | $70.93 Million | $-30.87 Million | -0.435x | -37.29% |
| 2023-06-30 | $71.46 Million | $-22.65 Million | -0.317x | +25.34% |
| 2022-06-30 | $59.51 Million | $-25.27 Million | -0.425x | -143.76% |
| 2021-06-30 | $83.36 Million | $-14.52 Million | -0.174x | -126.89% |
| 2020-06-30 | $-11.81 Million | $-7.65 Million | 0.648x | +151.07% |
| 2019-06-30 | $4.56 Million | $-5.78 Million | -1.269x | -41.85% |
| 2018-06-30 | $3.78 Million | $-3.38 Million | -0.894x | -34.64% |
| 2017-06-30 | $3.25 Million | $-2.16 Million | -0.664x | +12.45% |
| 2016-06-30 | $926.64K | $-703.00K | -0.759x | -887.57% |
| 2015-06-30 | $532.93K | $-40.94K | -0.077x | -- |